<DOC>
	<DOCNO>NCT00235469</DOCNO>
	<brief_summary>This phase 2b trial conduct approximately 60 site US investigate whether lacosamide ( SPM 927 ) different dos reduces pain subject diabetic neuropathy . Approximately 360 subject randomize placebo one three dos lacosamide . To qualify trial , subject symptom painful distal diabetic neuropathy range duration 6 month 5 year must average pain intensity ≥4 11-point Likert scale ( 0-10 scale ) 7 day period prior start treatment . To determine effect lacosamide diabetic neuropathic pain , subject use diary record daily pain intensity ( morning evening ) , pain interference sleep ( morning ) activity ( even ) . Use rescue medication ( acetaminophen ) subject ' quality life investigate . In addition , safety tolerability different dos lacosamide investigate .</brief_summary>
	<brief_title>A Trial Assess Efficacy Safety SPM 927 Subjects With Painful Distal Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Painful distal diabetic neuropathy Must average pain intensity ≥ 4 11point Likert scale</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>PAINFUL DISTAL DIABETIC NEUROPATHY</keyword>
</DOC>